MELINTA THERAPEUTICS, INC. /NEW/ (MLNT) has 9 open-market insider trades by 8 insiders since 2018. The most active filer is Vatera Holdings LLC, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Vatera Holdings LLC | Dir10% Owner | — | 2 | $127.9M | 2018-05-29 |
| Daniel Mark Wechsler | — | — | 1 | $250K | 2018-05-29 |
| David Zaccardelli | Dir | — | 1 | $200K | 2018-05-29 |
| John Johnson | CEO | — | 1 | $72K | 2019-06-27 |
| Paul Estrem | CFO | — | 1 | $50K | 2018-05-29 |
| David N. Gill | Dir | — | 1 | $30K | 2018-05-25 |
| Sue Cammarata | Chief Medical Officer | — | 1 | $20K | 2018-05-29 |
| Erin Duffy | Chief Scientific Officer | — | 1 | $20K | 2018-05-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| John Johnson | CEO | Sell | $72K | 2019-06-27 |
| David Zaccardelli | Director | Buy | $200K | 2018-05-29 |
| Erin Duffy | Chief Scientific Officer | Buy | $20K | 2018-05-29 |
| Daniel Mark Wechsler | — | Buy | $250K | 2018-05-29 |
| Vatera Holdings LLC | Director & 10% Owner | Buy | $76.9M | 2018-05-29 |
| Paul Estrem | CFO | Buy | $50K | 2018-05-29 |
Companies that share insiders with MLNT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| David N. Gill | Director | Buy | $30K | 2018-05-25 |
| Vatera Holdings LLC | Director & 10% Owner | Buy | $51.0M | 2018-01-05 |